The reasons Pfizer gave for it not being a success were -only about half of people covered by commercial health plans had easy access to it, and sales suffered because of higher rebates in the U.S. and unfavorable formulary positioning.
BOT - Anything but charting, page-11147
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.8¢ | 32.0¢ | $3.160M | 9.427M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 670399 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 24177 | 3 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |